| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects
|
Zhang, Tan
|
|
2018
|
33 |
1 |
p. 93-100
|
artikel
|
| 2 |
Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”
|
Niazi, Sarfaraz K.
|
|
2019
|
33 |
1 |
p. 121-123
|
artikel
|
| 3 |
Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers
|
Kim, Seokuee
|
|
2018
|
33 |
1 |
p. 101-112
|
artikel
|
| 4 |
Current Ebola Virus Vaccine Progress
|
Marzi, Andrea
|
|
2019
|
33 |
1 |
p. 9-14
|
artikel
|
| 5 |
Current Ebola Virus Vaccine Progress
|
Marzi, Andrea
|
|
|
33 |
1 |
p. 9-14
|
artikel
|
| 6 |
FKB327: An Adalimumab Biosimilar
|
Al-Salama, Zaina T.
|
|
2019
|
33 |
1 |
p. 113-116
|
artikel
|
| 7 |
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies
|
Busse, Paula J.
|
|
2018
|
33 |
1 |
p. 33-43
|
artikel
|
| 8 |
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
|
Suh, Chang-Hee
|
|
2019
|
33 |
1 |
p. 79-91
|
artikel
|
| 9 |
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities
|
Dholaria, Bhagirathbhai R.
|
|
2018
|
33 |
1 |
p. 45-60
|
artikel
|
| 10 |
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities
|
Dholaria, Bhagirathbhai R.
|
|
|
33 |
1 |
p. 45-60
|
artikel
|
| 11 |
Monoclonal Antibodies for Multiple Sclerosis: An Update
|
Graf, Jonas
|
|
2019
|
33 |
1 |
p. 61-78
|
artikel
|
| 12 |
Pegfilgrastim-jmdb/MYL-1401H: A Pegfilgrastim Biosimilar
|
Hoy, Sheridan M.
|
|
2019
|
33 |
1 |
p. 117-120
|
artikel
|
| 13 |
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
|
Virtanen, Anniina T.
|
|
2019
|
33 |
1 |
p. 15-32
|
artikel
|
| 14 |
The Impact of the Fecal Microbiome on Cancer Immunotherapy
|
Osman, Afaf E. G.
|
|
2019
|
33 |
1 |
p. 1-7
|
artikel
|
Tijdschrift beschrijving